Publication & Citation Trends
Most Cited Works
2,448
Publications
378 total
A phase III randomised study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancer.
Cited by 7
Semantic Scholar
ACR Appropriateness Criteria® Staging and Follow-Up of Primary Liver Cancer.
Cited by 2
Semantic Scholar
Reply: insurance should cover vancomycin for primary sclerosing cholangitis. OA
Cited by 1
Semantic Scholar
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Cited by 304
OpenAlex
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With <i>IDH1</i> Mutation PDF
Cited by 452
OpenAlex
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors PDF
Cited by 220
OpenAlex
Pancreatic cancer
Cited by 2,448
OpenAlex
Research Topics
Pancreatic and Hepatic Oncology Research
(202)
Cholangiocarcinoma and Gallbladder Cancer Studies
(163)
Cancer Genomics and Diagnostics
(115)
Gallbladder and Bile Duct Disorders
(51)
Peptidase Inhibition and Analysis
(32)
Frequent Co-Authors
Affiliations
Novartis (Switzerland)
American Cancer Society
American Society of Clinical Oncology
Memorial Sloan Kettering Cancer Center
The University of Texas MD Anderson Cancer Center